Jennifer L. Sherr
YOU?
Author Swipe
View article: Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes Open
Aims/hypothesis Teplizumab is approved in the USA and seven other countries to delay stage 3 type 1 diabetes onset in individuals ≥8 years of age with stage 2 type 1 diabetes. As part of a US Food and Drug Administration post-marketing req…
View article: Erratum. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial Diabetes Care 2025;48:1598–1606
Erratum. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial Diabetes Care 2025;48:1598–1606 Open
In the article cited above, the affiliation for author Michael C. Riddell was inadvertently listed as Insulet Corporation, Acton, MA. The correct affiliation for this author is School of Kinesiology and Health Science, York University, Tor…
View article: Perceptions of the Benefits and Risks of Novel Therapies for Type 1 Diabetes: A Qualitative Study
Perceptions of the Benefits and Risks of Novel Therapies for Type 1 Diabetes: A Qualitative Study Open
Despite concerns about the risks and drawbacks of novel therapies, most participants reported that they would consider trying disease-modifying and cell replacement therapies. There is no substitute for consulting people living with or car…
View article: Dietary Patterns for Weight and Glycemic Management in Persons With Type 1 Diabetes: A Meta-analysis of Clinical Trials
Dietary Patterns for Weight and Glycemic Management in Persons With Type 1 Diabetes: A Meta-analysis of Clinical Trials Open
Background Medical nutrition therapy is fundamental for managing glycemia and weight in type 1 diabetes, yet dietary guidance specific to this population and relevant subgroups is lacking. Purpose We synthesized the interventional literatu…
View article: Contrasting Adult vs. Pediatric populations in a cohort of at risk relatives: The TrialNet Pathway to Prevention Study
Contrasting Adult vs. Pediatric populations in a cohort of at risk relatives: The TrialNet Pathway to Prevention Study Open
ObjectiveAdults represent over half of incident type 1 diabetes, yet research on disease progression predominantly focuses on at-risk children. We aimed to compare autoantibody screening outcomes and type 1 diabetes progression in adults v…
View article: Contrasting Adult vs. Pediatric populations in a cohort of at risk relatives: The TrialNet Pathway to Prevention Study
Contrasting Adult vs. Pediatric populations in a cohort of at risk relatives: The TrialNet Pathway to Prevention Study Open
ObjectiveAdults represent over half of incident type 1 diabetes, yet research on disease progression predominantly focuses on at-risk children. We aimed to compare autoantibody screening outcomes and type 1 diabetes progression in adults v…
View article: Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial
Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial Open
OBJECTIVE To compare the efficacy of enabling Activity feature 60 (AF-60) or 30 min (AF-30) before prolonged exercise versus the automated mode (Auto) in adults and adolescents with type 1 diabetes wearing the Omnipod 5 System. RESEARCH DE…
View article: Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems
Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems Open
The landmark Diabetes Control and Complications Trial (DCCT) showed that glucose control is critical to reducing the risk of diabetes-related complications. This chapter outlines a series of innovations and investigations that followed the…
View article: Registration and Real-Life Studies on Automated Insulin Delivery Systems
Registration and Real-Life Studies on Automated Insulin Delivery Systems Open
Introduction: The Diabetes Control and Complications Trial (DCCT) clearly documented long-term beneficial effects on both micro- and macro-vascular complications associated with type 1 diabetes (T1D) by using intensive insulin therapy (IIT…
View article: Practical Considerations and Implementation of Automated Insulin Delivery Systems
Practical Considerations and Implementation of Automated Insulin Delivery Systems Open
Automated Insulin Delivery (AID) is in a new era of implementation challenges and opportunities for people with diabetes (PWD) and healthcare providers (HCPs). Beyond technologic variation, cost, access, and HCP endorsement/experience lead…
View article: Practical Considerations and Implementation of Automated Insulin Delivery Systems
Practical Considerations and Implementation of Automated Insulin Delivery Systems Open
The technological progress to date with automated insulin delivery (AID) has ushered in a new era of challenges and opportunities for people with diabetes (PWD), spotlighting implementation considerations. Beyond physiologic and technologi…
View article: Registration and Real-Life Studies on Automated Insulin Delivery Systems
Registration and Real-Life Studies on Automated Insulin Delivery Systems Open
Introduction: The Diabetes Control and Complications Trial (DCCT) clearly documented long-term beneficial effects on both micro- and macrovascular complications associated with type 1 diabetes (T1D) by using intensive insulin…
View article: Associations of CGM Metrics with Stimulated C-Peptide Measures in Youth with Recent-Onset Type 1 Diabetes
Associations of CGM Metrics with Stimulated C-Peptide Measures in Youth with Recent-Onset Type 1 Diabetes Open
Objective: Continuous glucose monitoring (CGM) measures could be a surrogate for stimulated C-peptide outcomes in type 1 diabetes trials. Research Design and Methods: CGM and mixed-meal tolerance test-derived C-peptide measures at time poi…
View article: Associations of CGM Metrics with Stimulated C-Peptide Measures in Youth with Recent-Onset Type 1 Diabetes
Associations of CGM Metrics with Stimulated C-Peptide Measures in Youth with Recent-Onset Type 1 Diabetes Open
Objective: Continuous glucose monitoring (CGM) measures could be a surrogate for stimulated C-peptide outcomes in type 1 diabetes trials. Research Design and Methods: CGM and mixed-meal tolerance test-derived C-peptide measures at time poi…
View article: Lifting the wellbeing of adolescents and young adults with type 1 diabetes: A feasibility study of the LIFT app
Lifting the wellbeing of adolescents and young adults with type 1 diabetes: A feasibility study of the LIFT app Open
LIFT was deemed engaging, safe and feasible with promising preliminary changes in psychological outcomes.
View article: Dietary patterns for weight and glycemic management in persons with type 1 diabetes: a meta-analysis of clinical trials
Dietary patterns for weight and glycemic management in persons with type 1 diabetes: a meta-analysis of clinical trials Open
Background Medical nutrition therapy is fundamental for managing glycemia and weight in type 1 diabetes, yet dietary guidance specific to this population and relevant subgroups is lacking. Purpose We synthesized the interventional literatu…
View article: Lifting the Wellbeing of Adolescents and Young Adults with Type 1 Diabetes: A Feasibility Study of the Lift App
Lifting the Wellbeing of Adolescents and Young Adults with Type 1 Diabetes: A Feasibility Study of the Lift App Open
View article: Limitations in Achieving Glycemic Targets from CGM data and Persistence of Severe Hypoglycemia in Adults with Type 1 Diabetes Regardless of Insulin Delivery Method
Limitations in Achieving Glycemic Targets from CGM data and Persistence of Severe Hypoglycemia in Adults with Type 1 Diabetes Regardless of Insulin Delivery Method Open
ObjectivesWe captured CGM metrics from a large, online survey of adults with type 1 diabetes to determine how glycemic outcomes varied by insulin delivery form.Research Design and Methods Adults with type 1 diabetes from the T1D Exchange R…
View article: Limitations in Achieving Glycemic Targets from CGM data and Persistence of Severe Hypoglycemia in Adults with Type 1 Diabetes Regardless of Insulin Delivery Method
Limitations in Achieving Glycemic Targets from CGM data and Persistence of Severe Hypoglycemia in Adults with Type 1 Diabetes Regardless of Insulin Delivery Method Open
ObjectivesWe captured CGM metrics from a large, online survey of adults with type 1 diabetes to determine how glycemic outcomes varied by insulin delivery form.Research Design and Methods Adults with type 1 diabetes from the T1D Exchange R…
View article: Limitations in Achieving Glycemic Targets From CGM Data and Persistence of Severe Hypoglycemia in Adults With Type 1 Diabetes Regardless of Insulin Delivery Method
Limitations in Achieving Glycemic Targets From CGM Data and Persistence of Severe Hypoglycemia in Adults With Type 1 Diabetes Regardless of Insulin Delivery Method Open
OBJECTIVE We captured continuous glucose monitoring (CGM) metrics from a large online survey of adults with type 1 diabetes to determine how glycemic outcomes varied by insulin delivery form. RESEARCH DESIGN AND METHODS Adults with type 1 …
View article: The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD) Open
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type …
View article: The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD) Open
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type …
View article: International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies – Insulin Delivery
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies – Insulin Delivery Open
The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with di…
View article: Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System Open
With increasing prevalence of obesity and cardiovascular diseases, there is a growing interest in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as an adjunct therapy in type 1 diabetes (T1D). The GLP-1RAs are currently no…
View article: Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes Open
Aim Automated insulin delivery (AID) systems have demonstrated improved glycaemic outcomes in people with type 1 diabetes (T1D), yet limited data exist on these systems in very young children and their impact on caregivers. We evaluated ps…
View article: Digital Gaming and Exercise Among Youth With Type 1 Diabetes: Cross-Sectional Analysis of Data From the Type 1 Diabetes Exercise Initiative Pediatric Study
Digital Gaming and Exercise Among Youth With Type 1 Diabetes: Cross-Sectional Analysis of Data From the Type 1 Diabetes Exercise Initiative Pediatric Study Open
Background Regular physical activity and exercise are fundamental components of a healthy lifestyle for youth living with type 1 diabetes (T1D). Yet, few youth living with T1D achieve the daily minimum recommended levels of physical activi…
View article: Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience
Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience Open
The use of verapamil in youth newly-diagnosed with T1D appears generally safe and well tolerated with appropriate monitoring. We strongly recommend monitoring for potential side effects including an ECG at screening and an additional ECG o…
View article: Exploring Factors that Influence Post-Exercise Glycemia in Youth with Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric Study (T1DEXIP)
Exploring Factors that Influence Post-Exercise Glycemia in Youth with Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric Study (T1DEXIP) Open
Objective: To explore 24-hour post-exercise glycemia and hypoglycemia risk, data from the Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) study were analyzed to examine factors that may influence glycemia. Research Design and Metho…
View article: Exploring Factors that Influence Post-Exercise Glycemia in Youth with Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric Study (T1DEXIP)
Exploring Factors that Influence Post-Exercise Glycemia in Youth with Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric Study (T1DEXIP) Open
Objective: To explore 24-hour post-exercise glycemia and hypoglycemia risk, data from the Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) study were analyzed to examine factors that may influence glycemia. Research Design and Metho…
View article: Exploring Factors That Influence Postexercise Glycemia in Youth With Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) Study
Exploring Factors That Influence Postexercise Glycemia in Youth With Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) Study Open
OBJECTIVE To explore 24-h postexercise glycemia and hypoglycemia risk, data from the Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) study were analyzed to examine factors that may influence glycemia. RESEARCH DESIGN AND METHODS Th…